Generalized Myasthenia Gravis
📧 Sign up to get email alerts when something new happens for Generalized Myasthenia Gravis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-02-07Clinical Trial Update: Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study) [Phase 3]
Phase 3 trial assessing safety and efficacy of eculizumab in refractory generalized myasthenia gravis has completed with results posted in 2…
-
FDA approval · 2012-12-21FDA Approved: SOLIRIS — Supplemental Application (Alexion Pharmaceuticals Inc.)
FDA approved a supplemental application for SOLIRIS (eculizumab) submitted by Alexion Pharmaceuticals, resulting in changes to the product l…
-
CLINICAL_TRIALS trial_result · 2010-07-30Clinical Trial Update: Efficacy and Safety Study of GB-0998 for Treatment of Generalized Myasthenia Gravis [Phase 3]
A Phase 3 efficacy and safety trial of GB-0998 for generalized myasthenia gravis has completed.